European Multicenter and Open-Label Controlled Randomized Trial to Evaluate the Efficacy of Sequential Treatment With Tacrolimus-Rituximab Versus Steroids Plus Cyclophosphamide in Patients With Primary Membranous Nephropathy (The STARMEN Study)
Latest Information Update: 09 Feb 2022
At a glance
- Drugs Rituximab (Primary) ; Tacrolimus (Primary) ; Cyclophosphamide; Methylprednisolone; Methylprednisolone
- Indications Membranous glomerulonephritis
- Focus Therapeutic Use
- Acronyms STARMEN
- 15 Jan 2020 Status changed from active, no longer recruiting to completed.
- 03 Jan 2019 Planned End Date changed from 1 Apr 2019 to 30 Jun 2019.
- 03 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 30 Jun 2019.